"10.1371_journal.pone.0097262","plos one","2014-05-16T00:00:00Z","Luis F López-Cortés; Pompeyo Viciana; José A Girón-González; Alberto Romero-Palacios; Manuel Márquez-Solero; Maria A Martinez-Perez; Miguel A López-Ruz; Javier de la Torre-Lima; Francisco Téllez-Pérez; Marcial Delgado-Fernández; Milagros Garcia-Lázaro; Fernando Lozano; Mohamed O Mohamed-Balghata; on behalf of Sociedad Andaluza de Enfermedades Infecciosas","Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain; Hospital Universitario Puerta del Mar, Cádiz, Spain; Hospital Universitario de Puerto Real, Cádiz, Spain; Hospital Universitario Virgen de la Victoria, Málaga, Spain; Hospital Universitario San Cecilio, Granada, Spain; Hospital Universitario Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Málaga, Spain; Hospital La Línea, Cádiz, Spain; Hospital Universitario Carlos Haya, Málaga, Spain; Hospital Universitario Reina Sofía, Córdoba, Spain; Hospital Universitario de Valme, Sevilla, Spain; Complejo Hospitalario de Jaén, Jaén, Spain; Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Sevilla, Spain","Conceived and designed the experiments: LFLC. Performed the experiments: LFLC PV JAGG ARP MMS MAMP MALR JdlTL FTP MDF MGL FL MMB. Analyzed the data: LFLC. Contributed reagents/materials/analysis tools: LFLC PV JAGG ARP MMS MAMP MALR JdlTL FTP MDF MGL FL MMB. Wrote the paper: LFLC. Other: Interpretation of the data: LFLC. Collection, assembly of data and database management: LFLC. Provision of data and patients: LFLC PV JAGG ARP MMS MAMP MALR JdlTL FTP MDF MGL FL MMB. Drafting of the article: LFLC. Critical revision of the article for important intellectual content: PV JAGG ARP MMS MAMP MALR JdlTL FTP MDF MGL FL MMB. Final approval of the article: LFLC PV JAGG ARP MMS MAMP MALR JdlTL FTP MDF MGL FL MMB.","The authors have read the journals policy and have the following conflicts: The authors have not conflicts of interest related to this manuscript. However, Luis F. López-Cortés, Pompeyo Viciana, José A. Girón-González, Manuel Márquez-Solero, Javier de la Torre-Lima, Marcial Delgado-Fernández, and Fernando Lozano have received honoraria for speaking at symposia organized on behalf of Abbott laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen-Cilag España, Merck Sharp & Dohme España, Roche Pharma SA, and ViiV Healthcare. Also, they have received unrestricted funds for research from Abbott Laboratories (Spain), Bristol-Myers Squibb, Bristol-Myers Squibb, Gilead Sciences, Glaxo Smithkline, Roche Pharma S.A., and ViiV Healthcare.","2014","05","Luis F López-Cortés","LFLC",14,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
